glp-1 or semaglutide A Review on Semaglutide: An Oral Glucagon-Like Peptide 1 Receptor Agonist in Management of Type 2 Diabetes Mellitus | Diabetes Therapy Another Weight-Loss Trial Win for

In late-stage clinical trials, people on the highest doses of retatrutide have lost 28% of their baseline weight on averagenumbers rivaling the typical success of gold-standard bariatric surgeries

CrossRef Studying serum immunoglobulin levels in metabolic dysfunction-associated steatotic liver disease Hazem Abosheaishaa, Emad Ahmad Awad Hussein, Shereen Abou Bakr Saleh, Mahmoud Nassar, Abdulaziz Elmaradny, Mohammed Abdelwahed, Amr Ali, Khaled Elfert, Ahmed Mohamed ElGhandour Egyptian Liver Journal .2026;[Epub] CrossRef Association Between Periodontitis and Metabolic DysfunctionAssociated Steatotic Liver Disease: A CrossSectional Study Mizuki Saito, Yoshihiro Shimazaki, Saori Yoshii, Tetsuhito Kojima Clinical and Experimental Dental Research .2026;[Epub] CrossRef Endoscopy for Metabolic Diseases Maria Valeria Matteo, Jana Kefah Ibrahim Hussein, Giorgio Carlino, Vincenzo Bove, Valerio Pontecorvi, Loredana Gualtieri, Martina De Siena, Mariachiara Di Vincenzo, Lorenzo Zileri Dal Verme, Daniele Salvi, Clarissa Ferrari, Cristiano Spada, Ivo Boskoski Journal of Clinical Medicine .2026

Obesity, commonly present in individuals with type 2 diabetes, independently increases venous thromboembolism risk through mechanical factors, chronic inflammation, and altered coagulation profiles

I always got some signal